KNOWLEDGE BANK

Interviews

ExpreS2ion Biotechnologies

Vice President - Business Development
ExpreSion Biotechnologies protein expression system ExpreS is an important protein expression tool in the scientists tool box for protein expression The ExpreS platform has demonstrated in many instances its usefulness in RD with several ExpreSmade proteins having now been crystallized

Articles

The Emergence of Organ-on-chips for Diseases Studies and Drug Development

In recent years Organonchips OOC attracted large interest as a new enabling technology to better understand human pathophysiological mechanisms and develop new drug treatments

Research Insights

COVID-19 Infection and Transmission Includes Complex Sequence Diversity

SARSCoV whole genome sequencing has played an important role in documenting the emergence of polymorphisms in the viral genome and its continuing evolution during the COVID pandemic Here we present data from over patients to characterize the complex sequence diversity of individual

Case Studies

Solid Form Changes During Drug Development: Good, Bad, And Ugly Case Studies

The relevance of solid form in drug development has been well established over time In order to fully understand drug properties attention has been paid to solid state structure of drug molecules and their relationship to the drug formulation While each drug developer has had their own strategies and workflows for screening and choosing solid forms of drug molecules t...

Techno Trends

Australian Scientists Discover Breakthrough in Lung Cancer Treatment

Australian scientists have discovered a breakthrough in lung cancer treatment They discovered the origin cell of a common form of lung cancer that kills thousands of smokers and nonsmokers This would help to detect squamous cell lung cancer that accounts for up to per cent of all lung cancers Scientists will take years to complete the breakthrough They observed...

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

TOP ARTICLES

1

Industry 4.0 at Bachem

Elodie Decuypere

Elodie Decuypere received her Ph.D in Organic Synthesis from the University of Paris-Saclay with specialization in Click Chemistry. After her Ph.D, Elodie specialized in oligonucleotide chemistry with her two postdoc in ETH Zürich and Roche Basel. In 2020, Elodie joined Bachem as a Specialist Marketing and works on the creation of scientific content for marketing materials.

 

2

Six Sigma - Time, cost and product quality improvement

Ashwin Kuchekar

Ashwin Kuchekar is an Associate Professor and the Head of Career Services and Placement at the School of Pharmacy, Dr. Vishwanath Karad MIT-WPU in Pune. He completed his M. Pharm.in 2009 and Ph. D. in 2015. In 2012, he received the Senior Research Fellow (SRF) Award from the Council of Scientific Industrial and Research (CSIR).  He is a trained specialist in Lean Six Sigma Black Belt (LSSBB).  He has 7 years of industrial experience in reputed pharmaceutical companies such as Piramal, Lupin, and Abbott Healthcare. He has a unique blend of statistics and formulation development, Quality by Design with exposure to branded and generic product development. He has practical experience in the Design of Experiments and product formulation and process optimisation.

 

3

Determinants of Antimicrobial Resistance (AMR) Research in South East Asia

Raja Chakraverty

Raja Chakraverty is a serving Scientist with the Indian Council of Medical Research with a decade long research and teaching career in Pharmaceutical Sciences with 54 publications (186 citations) and a book

 

Tatini Debnath

Doctoral Scholar, Department of Pharmaceutical Technology

4

The Growing Role of Biocatalysis in Industrial Synthesis

Dr Reuben Carr

Dr Reuben Carr has over 25 years of experience in developing proprietary biocatalytic processes for fine chemical and pharmaceutical manufacturing. He specialises in using directed evolution to engineer natural enzymes to carry out novel chemical reactions, enabling the synthesis of challenging molecular targets for clients and customers.

5

The Role of Technology in Continued Process Verification 4.0

Kavita Vengurlekar

Dr. Kavita is a seasoned leader in the field of data and insights, with over 20 years of invaluable experience. She is a result-oriented solution designer in data warehouse and big data analytics. Drawing from her extensive in multinational organisations IBM, Capgemini, and others, Kavita has successfully overseen numerous large and intricate projects. Her expertise lies in effectively leveraging her robust technical knowledge in areas such as data warehousing and business intelligence to drive impactful outcomes. Under Dr. Kavita's exceptional leadership, the CaliberAPQR product has achieved outstanding recognition.

 

press releasesRead more...

CAS Connections brings trusted scientific data and AI to leading R&D platforms

CAS a division of the American Chemical Society specializing in scientific knowledge management today announced CAS Connections a new integration framework that embeds the CAS Content Collection

Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®

Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA today announced the launch of AHZANTIVE aflibercept a biosimilar to Eylea in Europe further strengthening the Companys growing biosimilars portfolio and expanding

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Amneal Pharmaceuticals Inc Amneal or the Company Nasdaq AMRX today announced that the US Food and Drug Administration FDA has approved the Companys romidepsin injection solution mg mL

DaltonTx launches its drug discovery platform, Dalton, and announces Sygnature Discovery collaboration

DaltonTx the intelligence backbone for modern drug discovery connecting AI human expertise and experimental data today announced the launch of Dalton its drug discovery platform

Iovance’s Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

Iovance Biotherapeutics Inc NASDAQ IOVA a commercial biotechnology company focused on innovating developing and delivering novel polyclonal tumor infiltrating lymphocyte TIL therapies for patients with cancer

Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer

Arcus Biosciences Inc NYSE RCUS a clinicalstage global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer and inflammatory and autoimmune diseases

EventsRead more...

04 - 05

Jun 2026

Pharmac South 2026

Chennai Trade Centre, Nandamba...

04 - 05

Jun 2026

09 - 11

Jun 2026

5th World ADC Summit South Korea

COEX Magok Lewest, 143 Magokju...

09 - 11

Jun 2026

World TPD & Induced Proximity Summit South Korea

COEX Magok Lewest, 143 Magokju...

09 - 11

Jun 2026

World Targeted Therapeutics Summit South Korea

COEX Magok Lewest, 143 Magokju...

09 - 10

Jun 2026

ChemE Show 2026

George R. Brown Convention Cen...

10 - 11

Jun 2026

Novel Ingredients for Infant Nutrition Summit

The Westin Washington Dulles A...

10 - 11

Jun 2026

LATEST NEWSRead more...

Stipple Bio Signs Licensing Agreement with Lonza for Precision Oncology ADC Development

Stipple Bio has entered a multitarget licensing agreement with Lonza to support the development of nextgeneration antibodydrug conjugate ADC therapies for cancer treatment

Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy

Biogen announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to salanersen for the treatment of spinal muscular atrophy SMA

Chai Discovery Signs Licensing Agreement with Pfizer to Advance AI-Driven Drug Discovery

Chai Discovery has entered into a licensing agreement with Pfizer to support the use of artificial intelligence in drug discovery and accelerate the development of new medicines

Alnylam and Inceptive Partner to Accelerate RNAi Drug Discovery Using AI

Alnylam Pharmaceuticals Inc and Inceptive Nucleics Inc have entered into a strategic collaboration aimed at accelerating the discovery and development of RNA interference RNAi therapeutics through the use of artificial intelligence

Massive Bio and Optellum Partner to Improve Clinical Trial Access for Early-Stage Lung Cancer Patients

Massive Bio and Optellum have entered into a collaboration aimed at improving access to clinical trials for patients with earlystage nonsmall cell lung cancer NSCLC The partnership combines Optellums artificial intelligence

Travere Therapeutics Signs Licensing Agreement with Everest Medicines for Civorebrutinib

Travere Therapeutics has entered into an exclusive licensing and collaboration agreement with Everest Medicines for the development and commercialisation of civorebrutinib EVER an investigational oral Brutons tyrosine kinase